Wednesday 7th March 2018

08:30 Wednesday 7th

Affari 1 Pre-Congress Course 08:30 → 13:30
Menstrual cycle disorders: from adolescence to menopause

  • Frederick Naftolin The Hypothalamic-Pituitary-Gonadal Axis: Puberty, Menstrual Cycle Regulation, and Post-Reproductive Life
  • Sarah Berga Hypothalamic amenorrhea
  • Basil Tarlatzis Polycystic ovary syndrome
  • Alessandro D. Genazzani Metabolism, obesity, thinness and reproduction
  • Nick Panay Practical approaches to managing premature ovarian insufficiency

09:00 Wednesday 7th

Sala 226 Assembly 09:00 → 11:00
FISGE Meeting

11:30 Wednesday 7th

Sala 226 Assembly 11:30 → 13:30
FLEG Meeting

15:30 Wednesday 7th

Auditorium Opening Symposium 15:30 → 17:00
Intracrinology: the open door to the future

Chairperson/s: David Archer , Andrea R. Genazzani

  • Fernand Labrie Intracrinology –the exclusive source of sex steroids in postmenopausal women is prasterone
  • Celine Bouchard Healthy and sex steroid-deprived vagina-from preclinical to clinical characteristics
  • Rossella E. Nappi The medical impact of vulvovaginal atrophy /genitourinary syndrome of menopause

17:15 Wednesday 7th

Auditorium Opening Ceremony 17:15 → 18:00

  • The ISGE Executive Committee
    Andrea R. Genazzani,
    Martin Birkhaueser
    Tommaso Simoncini
  • The Scientific Societies and Institutions
    C N Purandare(FIGO) Pitfalls and limitations of current evidence generation,
    John J. Sciarra(ACOG),
    Mary Ann Lumsden (RCOG),
    Alessandro Genazzani (AIGE)

18:00 Wednesday 7th

Auditorium Opening Lecture 18:00 → 18:30
for the Bruno Lunenfeld Lecture: RANKL – from bone loss to breast cancer (introduced by Lunenfeld Bruno)

  • Josef M. Penninger RANKL – from bone loss to breast cancer

18:30 Wednesday 7th

Auditorium Opening Lecture 18:30 → 19:00
The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease (introduced by Frederick Naftolin)

  • Roberta Brinton Diaz The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease

19:00 Wednesday 7th

Poster Area Poster Session 19:00 → 21:00
From 1 To 176 See the posters that will be presented!

19:05 Wednesday 7th

Poster Area Poster Session 19:05 → 21:00
From 177 To 365 See the posters that will be presented!

Thursday 8th March 2018

08:30 Thursday 8th

Auditorium Meet the Experts 08:30 → 09:30

Chairperson/s: Jean Francois Arnal

  • Philipe Bouchard Selective progesterone receptor modulators (SPRMs): update on the clinical results in fibroids
  • Kristina Gemzell Danielsson SPRMs for contraception with added health benefits

Affari 1 Meet the Experts 08:30 → 09:30
Bilateral oophorectomy in pre-menopausal women

Chairperson/s: Martin Birkhaeuser

  • Walter Rocca It is time to stop unjustified oophorectomies
  • John Studd It is time we learn to treat oophorectomized women correctly

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 → 11:30
PCOS e dismetabolismo

Chairperson/s: Alessandro Genazzani

  • Vincenzina Bruni Fattori genetici ed epigenetici predisponenti la PCOS
  • Li Xiao Anthropometric index to predict insulin resistance in women with polycystic ovary syndrome in China
  • Antonio Cianci L’ insulino resistenza della PCOS e le strategie terapeutiche
  • Antonio Lanzone Il trattamento degli iperandrogenismi
  • Gianluca Gennarelli PCOS e rischio oncologico

Affari 2 Scientific Society Symposium 08:30 → 09:30
Contraception: interesting aspects – Organized by the European Society of Contraception and Reproductive Health (ESC)

Chairperson/s: Gabriele Merki , George Bartfai

  • Regine Sitruk-Ware Potential neurological benefits of progesterone and progestins used in contraception
  • Gabriele Merki Course and treatment of headaches and migraine in the pillfree interval
  • George Bartfai Contraception in women with seizure disorder

Verde Scientific Society Symposium 08:30 → 09:30
Update in Ovarian Cancer- Organized by the Société Européenne de Langue Franco-Allemande de Gynécologie-Obstétrique (SELFAGO)

Chairperson/s: Adolf E. Schindler , René Druckmann

  • Laura Knabben Genetic testing in ovarian cancer
  • Christian Singer Prevention strategies in women with hereditary breast and ovarian cancer syndromes
  • Walther Kuhn Impact of lymph node dissection in ovarien cancer
  • Emmanuel Barranger Advanced ovarien cancer: preoperative prediction of resectibility

Affari 4 Scientific Society Symposium 08:30 → 09:30
The Brazilian experience in Polycystic Ovary Syndrome – Organized by the Sociedade Brasileira de Ginecologia Endocrina (SOBRAGE)

Chairperson/s: Edmund Baracat

  • José Soares-Jr Leraglutide and bariatric surgery. Definituve treatment of PCOS patients
  • Nilson R. De Melo Benefits and harms of combined oral contraceptive in PCOS
  • Sebastiao de Medeiros Clinical and biochemical features of Brazilian PCOS patients

Onice Scientific Society Symposium 08:30 → 09:30
Panel Discussion “From Conception to delivery in Indian PCOS” – Organized by the PCOS Society of India

Chairperson/s: Sujata Kar

  • Sujata Kar .
  • Nalini Mahajan .
  • Anita Soni .
  • Ritu Joshi .
  • Madhuri Patil .

Sala 4 Scientific Society Symposium 08:30 → 09:30
Session organized by the German Society of Gynecological Endocrinology and Reproduction (DGGEF)

Chairperson/s: Ludwig Kiesel , Liselotte Mettler

  • Petra Stute Measuring active and healthy ageing
  • Martin Goette MicroRNAs – ready for endometriosis diagnostics ?
  • Annette Bachmann PCOS – a lifelong disorder ?
  • Amanda Machado Weber Metformin and endometrial function

09:45 Thursday 8th

Auditorium Symposium 09:45 → 11:15
Premature labor: how to prevent, how to manage

Chairperson/s: Peter Chedraui , Takeshi Maruo

  • Tomoyuki Fujii Omega-3 polyunsaturated fatty acid and preterm birth
  • Fabio Facchinetti Maintenance tocolysis. Still unsolved problem
  • Gian Carlo Di Renzo Prediction and prevention of preterm birth
  • Christian Egarter Progesterone: mode of action in preterm labor

Affari 1 Scientific Society Symposium 09:45 → 11:15
Alliance of the surgeon and gynecologist-endocrinologist in reproductive medicine – Organized by the Russian Association of Endometriosis

Chairperson/s: Leila Adamyan , Vladimir N. Serov

  • Leila Adamyan Endometriosis – an integrated approach of the treatment
  • Maria Yarmolinskaya Infertility in patients with gynecological diseases – the role of hormone therapy in the preparation for IVF and in the luteal phase support
  • Irena Kozachenko Optimization of infertility treatment results in gynecological patients. Role of the surgeon in the preparation for IVF. “Pros and cons”
  • Nana Tetruashvili Recurrent pregnancy loss
  • Martynov Sergei and Arakelyan Alek Postoperative synechiae, inconsistent uterine scar and niches. Methods of diagnosis, surgical and medical treatment

Affari 2 Symposium 09:45 → 11:15
ART – New therapies and new challenges: the individual factors

Chairperson/s: Paolo Artini , Zion Ben Rafael

  • Jacques Cohen Assisted reproductive technology treatments, limitations and prospects for mitochondrial disease carriers
  • Basil Tarlatzis The use of androgens or androgen – modulating agents in poor responders undergoing in vitro fertilization
  • Alberto Revelli Multivariate prediction model for IVF results: a tool to get benchmark

Verde Scientific Society Symposium 09:45 → 11:15
Menopause medicine: think sexuality! – Organized by the International Menopause Society (IMS)

Chairperson/s: Mary Ann Lumsden , Sunila Khandelwal

  • Susan Davis Sexuality and the postmenopausal woman
  • Rossella E. Nappi Treating sexual symptoms at midlife
  • Michael van Trotsenburg Sexuality of Transgender Persons
  • Susan Davis New process of care for HSDD

Affari 4 Scientific Society Symposium 09:45 → 11:15
Gynecological Endocrinology and the Women Health’s future – Organized by the Asociacion Latinoamericana de Endocrinología Ginecologica (ALEG)

Chairperson/s: Alejandro Paradas Caba , Alejandro Manzur

  • German Salazar Trends in contraceptives use among adolescents
  • Imelda Hernandez Long term polycystic ovarian syndrome complications
  • Selva Lima Obesity its gynecological endocrine repercussion
  • Cuauhtemoc Celis-Gonzalez MHT: risks and benefits
  • Gerardo Broutin Conclusions
  • Lidia Sosa Conclusions

Onice Oral Presentation 09:45 → 11:15
Amenorrhea and stress related hypothalamic disorders

Chairperson/s: Metella Dei , Laura Gaspari

  • Fabio Cesar Prosdocimi Effects of sex steroids on serum prolactin concentration in mice with metoclopramide-induced hyperprolactinemia
  • Antonio Mancini Oxidative stress as a link between hormonal picture and bone turnover in hypothalamic amenorrhea
  • Francesca Parissone Fertility preservation in a young woman with Turner-like phenotype due to chromosomic aberration
  • Anna Loktionova Diagnostic value LH and FSH levels in female patients with central hypogonadism
  • Aikaterini Giannouli Two interesting cases of primary amenorrhea with double pathology
  • Diletta Mauro Effects of estroprogestin therapy on premenstrual exacerbation of meniere’s disease
  • Anna Dittfeld The Use of Steroids by Gym Athletes: an Attempt to Diagnose the Problem Scale and Possible Causes
  • Aikaterini Giannouli Metabolic burden in adolescents with secondary Functional Hypothalamic Amenorrhea: is the risk real?
  • Vasileios Karountzos Total body fat mass combined with its distribution to trunk can predict menstrual recovery and positively influence the psychopathology of adolescents with Anorexia Nervosa
  • Dmitry Gusev A new index for the differential diagnosis of various forms of functional hypothalamic amenorrhea

Sala 4 Oral Presentation 09:45 → 11:15
Endocrine disorders and other pathologies: impact on reproductive function

Chairperson/s: Mario Maggi , Antonio S. Laganà

  • Anna Kostrzak Bone mineral density in women with hyperprolactinaemia.
  • PINAR BAHAT Effects of neural therapy in patients with abnormal (dysfunctional) uterine bleeding
  • Faina Guseinova The characteristics of disorders of reproductive function in women with genital tuberculosis
  • Mónica Flores-Ramos Testosterone levels comparison between bipolar and depressed women.
  • Pedro Antonio Regidor Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature
  • Sarah Johnson Failure to predict ovulation by Apps when applied to menstrual cycles of women trying to conceive
  • Svetlana Vorotnikova Features of pituitary-ovarian axis functioning in woman of reproductive age with acromegaly and Cushing’s disease.
  • Dimitrios Anastasios Bountouvas Spontaneous Conception After Hyperprolactinemia Treatment In Laron Syndrome Patient
  • Leonor Burgos Martínez Differences in gonadal hormone levels in women with treatment resistant depression and treatment responsive depression
  • Anna Dittfeld Epstein-Barr virus infection in patients with autoimmune thyroid disease
  • Ricardo Simoes Analysis of oxidative stress and apoptosis in the ovary of rats treated with soybean isoflavones
  • Anastasia Kudrytskaya Menstrual function and Endocrine Status in Kidney Transplanted Women

11:15 Thursday 8th


11:45 Thursday 8th

Auditorium Symposium 11:45 → 13:15
Estetrol and Breast Cancer

Chairperson/s: Nicoletta Biglia , Herjan Coelingh Bennink

  • Richard J. Santen Estetrol in animal in vivo studies
  • Risto Erkkola Estetrol in ex vivo explant cultures of human breast cancer tissue
  • Herjan Coelingh Bennink Estetrol treatment of advanced breast cancer

Affari 1 Symposium 11:45 → 13:15
Urogenital aging

Chairperson/s: Farook Al-Azzawi , Pierluigi Benedetti Panici

  • Nick Panay Impact and management of VVA / GSM – an evidence based approach
  • Tomi Mikkola Stress urinary incontinence risk in women using HRT
  • Camil Castelo Branco VVA in young women
  • Tommaso Simoncini Managing pelvic organ prolapse between hormones and surgery

Affari 2 Symposium 11:45 → 13:15
Reproductive impairment: from nature to therapies

Chairperson/s: Jonathan Ramsay , Moncef BenKhalifa

  • Alessandro D. Genazzani Stress and hypothalamic amenorrhea
  • Rossella E. Nappi New therapies for Impairment of female sexual desire
  • Gian Maria Busetto Male reproductive failure: how to face

Verde Symposium 11:45 → 13:15
Cardiovascular protection and life long risk factors: diagnosis and management

Chairperson/s: Sven Skouby

  • Irene Lambrinoudaki Obstetrical history and cardiovascular risk in later life
  • Sven Skouby HT: pharmacology tailored to women’s health
  • Antonio Cano Symptoms and hormones: fine-tuning atherosclerotic risk ?
  • Peter Collins Cardiovascular risk management in women – an update, what’s new ?

Affari 4 Scientific Society Symposium 11:45 → 13:15
Obesidad y su impacto en la salud reproductiva de la mujer – Organized by the Federacion Latina de Endocrinología Ginecologica (FLEG)

Chairperson/s: Nestor Siseles , Rafael Camacho

  • Greta Solis Epidemiology of overweight in Latin American women
  • Manuel Noelting Obesity: its impact on the menstrual cycle
  • Gustavo Gomez SOA, obesity and insulin resistance
  • Pablo Lavin Obesidad en mujeres en edad del climaterio
  • Gustavo A. Maciel Low grade chronic inflammation in brasilian obese PCOS
  • Javier Saavedra Trigliceridos y HDL. Importancia en DX y tratamiento de dislipidemias

Onice Oral Presentation 11:45 → 13:15
Pregnancy: abortion and recurrent pregnancy loss

Chairperson/s: Gian Carlo Di Renzo , Bruno Mozzanega

  • Gaurav Desai Second Trimester Medical Termination of Pregnancy with Combined Intracervical and Intravaginal Misoprostol: Comparative Analysis with Intravaginal Misoprostol-A Pilot Study.
  • Agnieszka Dubiel The prevalence of MTHFR gene mutation in AITD women with history of miscarriage
  • Irina Zhukova Pro- and antiapoptotic proteins BCL-2 and Bax in endometrium of patients with miscarriages.
  • Alana Agnaeva Role of NK cells in early reproductive losses
  • Natasha Kashyap Role of altered Notch signalling in the pathogenesis of recurrent pregnancy loss (RPL): A northeast Indian cohort based pilot study
  • Margarita Bakleicheva The role of vitamin D for threatened miscarriage in the first trimester of pregnancy
  • Irina Zhukova Intracellular pattern-recognition receptors, recognizing viruses, in pathogenesis of missed and spontaneous abortions.
  • Elena Khazova Two seasons of the level of calcidiol in pregnant women of St. Petersburg.
  • Anjuma Begum Role of low vitamin d3 levels and linked deregulated placental apoptosis in recurrent pregnancy loss (RPL) pathogenesis: a study from northeast India
  • Amélie Keller Concentration of vitamin d from neonatal dried blood spots and the relation to gestational age, birthweight and ponderal index: the d-tect study

Sala 4 Oral Presentation 11:45 → 13:15
Assisted Reproduction Technologies: from induction of ovulation to endometrial receptivity therapies

Chairperson/s: Jacques Cohen , Alberto Revelli

  • Maria Costanza Chiti A tailored protocol for human ovarian follicle isolation for clinical application
  • samir Elsayed Higher Body Mass Index Significantly Affects Intracytoplasmic Sperm Injection Success Rate
  • Leila Nazari Effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial
  • AISHA ELBAREG Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP): Our Experience
  • Natalia Pasman Regulatory T cells in the ovarian follicular fluid of infertile women
  • Anastasia Beta Clomiphene Citrate in addition to gonadotropins may improve ovarian response in poor responders
  • Miguel Estrada Supplementation of exogenous LH in patients with poor ovarian response in controlled ovarian stimulation.
  • Mirela Iancu Does vitamin D influence the in vitro fertilization outcome?
  • Livia Munhoz Does high progesterone levels on ovarian stimulation cycles damage the quality oocytes collected?
  • Loris Marin The impact of thyroid autoimmunity on embryo quality in women undergoing assisted reproductive technology.
  • Lu Wang DAF promotes endometrial cells proliferation and motility under ovarian hormone stimulation
  • Oxana Melkozerova Tissue and molecular effects of the cavitated solution in the endometrial receptivity rehabilitation of patients with the uterine infertility

12:00 Thursday 8th

Affari 0 Sponsored Key Lecture 12:00 → 12:30

    12:45 Thursday 8th

    Affari 0 Sponsored Key Lecture 12:45 → 13:15

      13:30 Thursday 8th

      Affari 1 Sponsored Lunch Symposium 13:30 → 15:15

        Affari 0 Sponsored Lunch Symposium 13:30 → 15:15

          15:15 Thursday 8th


          15:45 Thursday 8th

          Auditorium Meet the Experts 15:45 → 16:45
          Should we re-think the role of gonadotrophins after the menopause?

          Chairperson/s: Philippe Bouchard

          • Tommaso Simoncini Gonadotrophins and breast cancer
          • Xiaodong Fu Gonadotrophins and cardiovascular disease

          Affari 1 Sponsored Meet the Experts 15:45 → 16:45

            Affari 0 Meet the Experts 15:45 → 16:45
            Stress and reproduction

            Chairperson/s: Anna Maria Paoletti

            • Sarah Berga Does stress causes infertility?
            • Alessandro D. Genazzani Integrative treatment to overcome the neuroendocrine impairment

            Affari 2 Sponsored Meet the Experts 15:45 → 16:45

              Verde Sponsored Meet the Experts 15:45 → 16:45

                Affari 4 Meet the Experts 15:45 → 16:45
                Ovarian tumors

                Chairperson/s: Javier Domingo

                • Manuel Nölting Androgen secreting tumors
                • Pierluigi Benedetti Panici Update on cytoreductive surger for advanced ovarian cancer

                Onice Oral Presentation 15:45 → 16:45
                Endometrial Hyperplasia and Endometrial Cancer

                Chairperson/s: Massimiliano Fambrini , Attilio Di Spiezio Sardo

                • Chunlin Su Effect and evaluation of hysteroscopy on Fertility-preserving Treatment of endometrial atypical hyperplasia and early endometrial adenocarcinoma in PCOS patients :a retrospective study
                • Xing Wei Effect of electric field on endometrial adenocarcinoma cell and NO secretion
                • Cristina Benetti-Pinto The use of tamoxifen as a malignancy risk in women with endometrial polyp
                • Tamara Knific Sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer
                • Madina Dumanovskaya Atypical endometrial hyperplasia is always equivalent refers to endometrial intraepithelial neoplasia, whereas it is not always endometrial intraepithelial neoplasia refers to atypical endometrial hyperplasia
                • Mariami Andguladze Endometrial Hyperplasia – New Vector of Treatment
                • Huixiao Wang Effects of 17β-estradiol on endometrial cancer cell proliferation and HOTAIR expression
                • Chunlin Su Reverse of Endometrial Atypical Hyperplasia and Early endometrial carcinoma in PCOS women by Dydrogesterone plus Metformin:a pilot study
                • Gonda Konings Blocking 17β hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach

                Sala 4 Oral Presentation 15:45 → 16:45
                Gynecological Surgery

                Chairperson/s: Liselotte Mettler , Marie-Madeleine Dolmans

                • Gaurav Desai Robotically assisted hysterectomy for staging endometrial cancer: Experience at a tertiary care institution in India
                • Gianluca Damiani Comparison of the perioperative outcomes of vessel sealing instrument –assisted technique hysterectomy with conventional hysterectomy
                • Anna Rosner-Tenerowicz The assessment CO2 laser treatment of vulvovaginal atrophy and its influence on urine incontinence
                • Mariana Rebeca Garcia Elias Laparoscopic neovagina creation by davydov’s procedure: evaluation of the vaginal function and sexual satisfaction with follow-up to one year.
                • Bakhodir Kurbanov Improved surgical technique to treatment of genital prolapse.
                • Salvatore Giovanni Vitale Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: anatomical and functional outcomes, quality of life and sexual function.

                16:45 Thursday 8th

                Auditorium Symposium 16:45 → 18:15
                Premature Ovarian Insufficency

                Chairperson/s: Camil Castelo-Branco , Walter Rocca

                • Farook Al-Azzawi Determinants of oocytes reserve and depletion
                • Nick Panay POI: progress through a global registry
                • Bart CJM Fauser POI: implications for cardiovascular health
                • Svetlana Vujovic Hypoestrogenism and insulin resistance in premature ovarian insufficiency: is it time dependent?

                Affari 1 Symposium 16:45 → 18:15
                Fertility preservation: possibilities and strategies

                Chairperson/s: Christian Egarter , Antonio Lanzone

                • Zion Ben Rafael The dilemma of social freezing
                • Marie-Madeleine Dolmans Ovarian tissue cryopreservation and transplantation: which success for 2018 ?
                • Javier Domingo Oocyte cryopreservation or tissue transplantation for fertility preservation in cancer patients: what is best ?

                Affari 0 Symposium 16:45 → 18:15
                The role of exogenous sex hormones in pregnancy (Organized by the PREIS School Academy session)

                Chairperson/s: Gian Carlo Di Renzo , Peter Platteau

                • Peter Platteau Role of exogenous sex hormones in medically assisted pregnancy
                • Mary Stephenson Role of sex hormones in recurrent pregnancy loss
                • Paul Piette The basics of progestogens and estrogens
                • Gian Carlo Di Renzo Role of exogenous sex hormones in perinatal period and on the preterm new born

                Affari 2 Sponsored Symposium 16:45 → 18:15

                  Verde Symposium 16:45 → 18:15
                  Menopausal transition

                  Chairperson/s: Antonio Cano , Susan Davis

                  • Tommaso Simoncini Neuroendocrine changes of the menopausal transition
                  • Pauline Maki Cognition and hot flashes: a scientific update
                  • Mary Ann Lumsden Following Guidelines – what should we say to those with heart disease ?
                  • Santiago Palacios Effects and management of the menopausal transition on vulvo-vaginal tissue

                  Affari 4 Oral Presentation 16:45 → 18:15
                  Polycystic Ovary Syndrome

                  Chairperson/s: Manuel Noelting , Andrea Giannini

                  • Shahnoza Kalanhodjaeva Comparative analysis of clinical and hormonal parameters in women with hyperandrogenemia adrenal and ovarian genesis
                  • Geranne Jiskoot Effects on body weight of a 1-year three-component lifestyle RCT in obese PCOS women.
                  • Gokce Anik Ilhan Cardiotrophin-1 as a new metabolic biomarker in women with PCOS.
                  • Elene Asanidze Anti-Mullerian Hormone is a Useful Marker for the Assessment of the Treatment Efficiency in Patients with Polycystic Ovary Syndrome (PCOS)
                  • Adam Czyzyk Evolving endocrine and metabolic milieu of PCOS with aging
                  • Mariana Paulson Endometrial expression of anti-müllerian hormone and its receptor in obese women with PCOS- a lifestyle intervention study
                  • Szilvia Csehely Laboratory and etiology characteristics of PCOS phenotypes
                  • Rhea Jabbour Assessment of carotid intima-media thickness in patients with polycystic ovary syndrome and its association with hormonal and lipid profiles
                  • Chiara Sabbadin Vitamin D deficiency in polycystic ovary syndrome
                  • Aleksandra Atanasova Boshku Lipid Accumulation Product (LAP), Waist to Hip Ratio (WHR) and Waist Circumference to Height Ratio (WGtR) associated with hormonal profile in women with Polycystic ovary syndrome
                  • Aleksandra Atanasova Boshku Hyperandrogenemia and lipid profile in women with polycystic ovary syndrome
                  • Hilma Lubis Fibrinolytic Activity in Woman with Polycystic Ovary Syndrome (PCOS)
                  • Swati Sharma evaluation of effect of vitamin D supplementation on serum AMH in vitamin D deficient PCOS women

                  Onice Oral Presentation 16:45 → 18:15
                  Endometriosis: ethiology and pathogenesis

                  Chairperson/s: Giuseppe Morgante , Silvia Vannuccini

                  • Tianjiao Pei miR-194-3p represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis
                  • Manijeh Mehdinejad Endometriosis and adenomyosis in adolescents, fertile and menopausal women
                  • Lutz Konrad Endometrium and Endometriosis – It is all the same from a cellular perspective
                  • Antonella Biscione DHEA and DHEA-S concentrations in plasma and saliva samples of women affected by endometriosis
                  • Yana Aznaurova Transcriptomic data of eutopic endometrium as a basis for a minimally invasive test of endometriosis.
                  • Maša Sinreih AKR1C3 levels in ovarian, peritoneal and deep infiltrating endometriosis
                  • Javier García Solares The concept of invasion in deep nodular endometriosis.
                  • Li Xiao miR22-5p targets TET2 and regulates the Estrogen receptor 2 expression in infertile women with mild or minimal endometriosis during implantation window

                  Sala 4 Oral Presentation 16:45 → 18:15
                  Breast Cancer

                  Chairperson/s: Risto Erkkola , Christian Singer

                  • Christel Pequeux Dose-dependent effect of estetrol (E4) on mammary gland and breast cancer: an opportunity for new menopause treatments
                  • Ambrogio P Londero Breast cancer development in patients with borderline breast lesions
                  • Marina Willibald Progesterone Receptor Membrane Component-1 is Phosphorylated upon Progestin Stimulation and Binds to Estrogen Receptor α-Coregulators PHB1 and PHB2 in Breast Cancer Cells
                  • Marina Willibald PGRMC1 Promotes Tumour Progression of Breast Cancer through Upregulation of ERα Expression and EGFR signalling
                  • Anna Rasmussen Adult granulosa cell tumor associated with breast cancer in Denmark 1964-2016
                  • Foteini Anifantaki Hormone receptor expression in pregnancy- associated breast cancer: a systematic review of the literature
                  • Vanessa Trindade Evaluation of ovarian function in young women after breast cancer chemotherapy treatment
                  • Xiaosa Li GPER1 Promotes Estrogen Receptor Negative Breast Cancer Cells Migration and Invasion via Nongenomic Activation of c-Src/NF-κB/Focal Adhesion Kinase Cascade

                  18:15 Thursday 8th

                  Auditorium ISGE General Assembly 18:15 → 19:30
                  ISGE General Assembly

                  Affari 1 Scholarship Course 18:15 → 19:30
                  Scholarship Course

                  • Howard Carp Obstetric Endocrinology
                  • Richard J. Santen Hormones and Cancers

                  Friday 9th March 2018

                  08:30 Friday 9th

                  Auditorium Meet the Experts 08:30 → 09:30
                  Progesterone and SPRMs effects on endometrium for decidualization and receptivity

                  Chairperson/s: Anna Glasier

                  • Fernando Reis Progesterone-induced paracrine factors in human endometrium: the key for decidualization and receptivity
                  • Bruno Mozzanega Ulipristal and the human endometrium: : the case of Emergency contraception

                  Affari 1 Meet the Experts 08:30 → 09:30
                  The vaginal and endometrial microbiota

                  Chairperson/s: Svetlana Vujovic

                  • Gary Ventolini Intravaginal and endometrial microbiota are important for human reproduction
                  • Inmaculada Moreno Study of the endometrial microbiota to improve ART outcomes

                  Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 → 11:30
                  Management della Terapia Ormonale Sostitutiva

                  Chairperson/s: Carmine Nappi

                  • Rossella E. Nappi Sintomi climaterici come marker di vulnerabilità biologica
                  • Anna Maria Paoletti Quando integrazione e quando sostituzione ormonale
                  • Vincenzo De Leo PCOS e menopausa: nuove opzioni terapeutiche
                  • Angelo Cagnacci L’evoluzione della TOS: combinata ciclica o continua, steroidi di sintesi o TSEC

                  Affari 2 Scientific Society Symposium 08:30 → 09:30
                  Gynecological surgery: from complications to new possibilities – Organized by the International Academy of Human Reproduction (IAHR)

                  Chairperson/s: Leila Adamyan , John Sciarra

                  • Liselotte Mettler Fibroids and malignancy potentials in reproductive surgery
                  • Joseph Schenker Complications of ART technology
                  • Andrea Giannini, Tommaso Simoncini Horizons in gynecologic robotic surgery

                  Verde Scientific Society Symposium 08:30 → 09:30
                  Hot topics in Gynecological Endocrinology – Organized by the Polish Society of Gynecological Endocrinology

                  Chairperson/s: Blazej Meczekalski , Andrzej Milewicz

                  • Grzegorz Breborowicz Obesity – what kind of problem it is in contemporary perinatology?
                  • Agnieszka Podfigurna Hyperandrogenism related to androgen secreting ovarian tumors
                  • Krzysztof Lukaszuk Endometrial receptivity and luteal phase support
                  • Blazej Meczekalski Fertility in women of late reproductive age

                  Affari 4 Scientific Society Symposium 08:30 → 09:30
                  Aspects related to middle-aged women – Organized by the Asociacion Argentina para el estudio del Climaterio (AAPEC)

                  Chairperson/s: Rita Caro , Elida Rodriguez

                  • Claudia Rey Osteopenia: when and how to intervene?
                  • Monica Nanez Are local hormones really important in genitourinary urinary tract?
                  • maria belardo Sleep disorders in perimenopausal women, and metabolic syndrome
                  • Blanca Campostrini Treatments for menopausal symptoms: which are the best options.?
                  • Cristina Montero Discussion

                  Onice Scientific Society Symposium 08:30 → 09:30
                  Male Contraception under the auspices of ICMC – Organized by the International Consortium for Male Contraception (ICMC)

                  Chairperson/s: David Serfaty , Regine Sitruk-Ware

                  • David Serfaty Activities and update of ICMC
                  • Cristina Meriggiola Overview on male hormonal contraception
                  • Regine Sitruk-Ware Possible non contraceptive benefits of hormonal male contraception
                  • Mario Festin WHO efficacy study on male contaception: last update

                  Sala 4 Oral Presentation 08:30 → 09:30
                  Gynecological Cancers

                  Chairperson/s: Massimo Stomati , Franco Borruto

                  • Giorgio Bogani Potential Implication on the Introduction of the Nonavalent Vaccination Against HPV: an analysis HPV prevalence in 13,665 patients over a 18-year study period
                  • Maria Luisa Gasparri Immune response to Chemotherapy-Associated Antigens as preoperative predictor of oncologic outcome in Ovarian Cancer patients: a pilot study
                  • Hexia Xia Follicle loss and PTEN/PI3K/mTOR signaling pathway activated in LepRb-mutated mice
                  • Alexandra Asaturova Innovative liquid-based cytology of fallopian tube smears in intraepithelial precancerous lesions diagnostics
                  • Anna Protasova Safety of prescribing MGT after successful treatment of CIN and squamous cell carcinoma of the cervix.
                  • Bruna De Almeida Expression of miR-148a, miR-152 and miR-21 and genetic interactions network in uterine leiomyosarcoma cells
                  • Giorgio Bogani Introducing Nerve-Sparing Approach during Minimally Invasive Radical Hysterectomy for Locally-Advanced Cervical Cancer: A multi-Institutional Experience

                  09:45 Friday 9th

                  Auditorium Symposium 09:45 → 11:15
                  Neurosteroids as regenerative agents

                  Chairperson/s: Cordian Beyer , Luis M. Garcia-Segura

                  • Roberta Brinton Diaz Allopregnanolone as a therapeutic to regenerate the degenerating brain
                  • Michael Schumacher Progesterone and stroke
                  • Regine Sitruk-Ware Effects of progesterone and nestorone on myelin

                  Affari 1 Scientific Society Symposium 09:45 → 11:15
                  Alternative treatment methods of patients with benign tumors and hyperplastic processes of the uterus in women of reproductive age- Organized by the Russian Society of Reproductive Medicine and Surgery

                  Chairperson/s: Leila Adamyan , Vladimir N. Serov

                  • Leila Adamyan Management of patients with uterine fibroids from the age perspective
                  • Vitaly Bezhenar Combined hyperplastic processes of the organs of reproductive system in women with infertility
                  • Victoria Kasyan Medical aspects of contraception
                  • Galina Chernukha PCOS and infertility
                  • Elena Andreeva Role of the gynecologist in the detection of benign breast tumors from the perspective of cancer prevention

                  Affari 2 Sponsored Symposium 09:45 → 11:15

                    Verde Symposium 09:45 → 11:15
                    PCO: genetic, epigenetic and metabolic risk factors

                    Chairperson/s: Xiangyan Ruan , Basil Tarlatzis

                    • Jerome Strauss Genetic and epigenetic factors contributing to the hyperandrogenemia of PCOS
                    • Charles Sultan Adolescent PCOS: an entity?
                    • Alessandro D. Genazzani Metabolic impairment and new therapeutic strategies for PCOS
                    • Andrzej Milewicz Serum bisphenol A and metabolic profile in women with PCOS
                    • Archil Khomasuridze PCOS: the new approach

                    Affari 4 Scientific Society Symposium 09:45 → 11:15
                    Clinical challenges in the menopause transition – Organized by the Latino-American Federation of Climateric and Menopause Societies (FLASCYM)

                    Chairperson/s: Sonia Cerdas , Zully Benitez

                    • Sonia Cerdas The endocrinology of menopause transition
                    • Nestor Siseles Risks and indications of contraception
                    • Alejandro Paradas Achieving pregnancies during MT
                    • Maria Teresa Espinoza Hot flashes and migraines approach
                    • Silvina Witis Management of abnormal bleeding
                    • Cuauhtemoc Celis-Gonzalez Bone health during MT
                    • Alejandra Elizalde Cremonte Questions and closing remarks
                    • Greta Solis Questions and closing remarks
                    • Maria Alejandra Schuele Questions and closing remarks

                    Onice Scientific Society Symposium 09:45 → 11:15
                    Role of progestogens in women’s health: an up-date – Organized by the European Progestogen Club (EPC)

                    Chairperson/s: Adolf E. Schindler , René Druckmann

                    • Pedro-Antonio Regidor Role of progestogens in women’s health: an update. Clinical relevance in present day hormonal contraception
                    • Alfred Mueck Choice of progestogen for HRT in menopausal women
                    • Sven Skouby Impact of progestogenes on hemostasis
                    • Nicola Pluchino Brain progesterone metabolite: Allopregnanolone production and its regulation
                    • Vitaly Tskhay Results of hormone therapy and recovery of the patients with severe forms of adenomyosis

                    Sala 4 Oral Presentation 09:45 → 11:15
                    Menopause: vascular effects and cardiovascular diseases

                    Chairperson/s: Damir Franic , Margaret Rees

                    • Alfred Mueck Vasodilative potency induced with Estradiol in women with and without CAD during standardized stress:- two parallized, randomized, double-blind, placebo-controlled cross-over studies
                    • Anna Dalla Cà Acute effect of estrogens stimulation -triptorelin induced on heart ECG parameters in patients with polycystic ovary syndrome
                    • Tord Naessen Improved inflammation markers during menopausal hormone therapy correlate to ultrasonographic signs of vascular benefit. – a randomized-controlled study
                    • Yizhou Huang Function and mechanism of estrogen in regulating vascular endothelial barrier
                    • Anne Gallez Inclusion of 17β-estradiol into liposome: a new tool to study the molecular mechanisms of estrogen receptors
                    • Mahsa Noroozzadeh The effect of prenatal exposure to a single dose of testosterone on cardiac function of male and female rats in adulthood
                    • Cindy Meun High androgen levels in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study
                    • Ping Li 17b-Estradiol Enhances Vascular Endothelial Ets-1/ miR-126-3p Expression: The Possible Mechanism for Attenuation of Atherosclerosis
                    • Eleni Armeni The TYG index as a potential predictor of subclinical vascular disease after the menopause
                    • Hai Jiang Changes in cardiovascular function based on adrenalin and norepinephrine metabolism in ovariectomized rats
                    • Hai Jiang Proteomics in plasma of ovariectomized rats and those exposed to estradiol valerate

                    11:15 Friday 9th


                    11:45 Friday 9th

                    Auditorium Symposium 11:45 → 13:15

                    Chairperson/s: Roberta Brinton , Michael Schumacher

                    • Luis Garcia-Segura Neuroprotective action of estradiol and estrogen receptors
                    • Walter Rocca Sex, gender, and the decline of dementia
                    • Andrea R. Genazzani Adrenal androgens impact on neurosteroids
                    • Cordian Beyer Estradiol control of brain inflammation and pyroptosis

                    Affari 1 Symposium 11:45 → 13:15

                    Chairperson/s: Duru Shah , Jerome Strauss, III

                    • Charles Sultan Management of adolescent hyperandrogenism: still a challenge !
                    • Angelica Hirschberg The role of androgens for body composition and physical performance in women
                    • Susan Davis Testosterone and cardiovascular health after menopause, a benefit or risk?
                    • Zana Bumbuliene Hyperandrogenism in adolescents

                    Affari 2 Symposium 11:45 → 13:15
                    Osteoporosis: a long life risk for women

                    Chairperson/s: Mark Brincat , Faustino Perez-Lopez

                    • Martin Birkhaeuser Prevention of osteoporosis in anorexia nervosa: what is new?
                    • John Stevenson HRT for prevention of osteoporosis
                    • Tobias De Villiers New drug development in osteoporosis

                    Verde Symposium 11:45 → 13:15
                    Endometriosis/Adenomyosis: from basic science to clinics

                    Chairperson/s: Leila Adamyan , Luigi Devoto

                    • Caterina Exacoustos The role of transvaginal U/S in the diagnosis of endometriosis and adenomyosis
                    • Ludwig Kiesel Regulation of proliferation and invasion in endometriosis
                    • Robert Taylor Cell biology of nascent endometriosis implants
                    • Nicola Pluchino Role of bone marrow-derived cells in endometriosis development

                    Affari 4 Scientific Society Symposium 11:45 → 13:15
                    Management of healthy ageing – Organized by the European Menopause and Andropause Society (EMAS)

                    Chairperson/s: Tommaso Simoncini , Irene Lambrinoudaki

                    • Michael van Trotsenburg Aging in Transgender Men and Women
                    • Margaret Rees Diet and lifestyle interventions for midlife health and beyond
                    • Alfred Mueck Impact of menopausal hormone therapy on morbidity and mortality
                    • Antonio Cano () Concept of healthy ageing according to EIP on AHA

                    Onice Oral Presentation 11:45 → 13:15
                    Assisted Reproduction Technologies: predictive markers, OHSS and ethical aspects

                    Chairperson/s: Inmaculada Moreno , Elisabetta Coccia

                    • Giulia Murru Plasmatic androgens as predictors of ovarian response in ART: a prospective cohort study.
                    • Antonio Mancini Infertility as an indication for provocative testing of Growth Hormone
                    • Svetlana Zhukovskaya Prognostic markers of ovarian hyperstimulation syndrome in assisted reproductive technologies
                    • Amerigo Vitagliano Endometrial scratch injury before intrauterine insemination: Is it time to re-evaluate its value? Evidence from a systematic review and meta-analysis of randomized controlled trials.
                    • Piyush Bansal The role of GnRH analogues(GnRH-a) in improving outcome in women undergoing super-ovulation (SO) and intra-uterine insemination (IUI) after surgical correction of minimal to mild endometriosis: a randomized control trial.
                    • Diana Mihai What to do with the surplus cryopreserved embryos? The view in accordance with the principles of bioethics
                    • Parnaz Borjian Boroujeni Thrombophilic genes alterations as risk factor for OHSS
                    • Tiffanny Jones Lavender aromatherapy to reduce anxiety during intrauterine inseminations: a randomized, controlled trial
                    • Taisiia Yurchuk Multiple pregnancy rate and single transfer of either fresh or cryopreserved embryo.

                    Sala 4 Oral Presentation 11:45 → 13:15
                    Pre-Eclampsia and Pregnancy Induced Hypertension

                    Chairperson/s: Fernando Reis , Filiberto Severi

                    • Tetiana Loskutova New approaches to the prognosis of preeclampsia in pregnant woman
                    • Dorota Darmochwal-Kolarz The role of Placental Growth Factor and Endoglin in the pathogenesis of pre-eclampsia
                    • Lucia Maria Procopciuc Newborn genotypes associated with endothelial dysfunction as a risk factor for mild and severe preeclampsia
                    • Svetlana Dubrovina Early predictors of late-onset preeclampsia
                    • Marta Hentschke Alterations and association in Endocan-1 and placental growth factor in women with pre-eclampsia
                    • Lutfiya Karimova Genes of vascular tone polymorphism and PE risks in Uzbek population
                    • Natalya Yakovleva Matrix metalloproteinase-12 is a predictor of pre-eclampsia?
                    • Anna Drobintseva Placental kisspeptin and annexin V protein expression in preeclamptic pregnancies
                    • Fabio Barra Incidence of pregnancy induced hypertension (PIH) and small-for-gestational-age (SGA) infants in oocyte-donation (OD) pregnancies: a prospective comparative study
                    • Sapiyat Ibragimova Markers for prediction early and late preeclampsia and fetal development delay
                    • Umida Ashurova Polymorphism of candidate genes associated with the risk of developing gestational hypertension

                    12:00 Friday 9th

                    Affari 0 Sponsored Key Lecture 12:00 → 12:30

                      12:45 Friday 9th

                      Affari 0 Sponsored Key Lecture 12:45 → 13:15

                        13:30 Friday 9th

                        Affari 1 Sponsored Lunch Symposium 13:30 → 15:15

                          Affari 2 Lunch Symposium 13:30 → 15:15
                          Evolution in contraception in 2018

                          Chairperson/s: Santiago Palacios

                          • Rossella E. Nappi Evolution in contraceptive vaginal rings
                          • Illam Baram Evolution in intrauterine contraception

                          15:15 Friday 9th


                          15:45 Friday 9th

                          Auditorium Key Lecture 15:45 → 16:15
                          Only Estrogen-Only is good for Breast Cancer

                          Chairperson/s: Anne Gompel

                          • Herjan Coelingh Bennink Only Estrogen-Only is good for Breast Cancer

                          Affari 1 Key Lecture 15:45 → 16:15
                          Endometriosis and adenomyosis in adolescents, fertile and menopausal women

                          Chairperson/s: John Sciarra

                          • Leila Adamyan Endometriosis and adenomyosis in adolescents, fertile and menopausal women

                          Affari 0 Key Lecture 15:45 → 16:15
                          The ovarian renin-angiotensin system

                          Chairperson/s: Jean Michel Foidart

                          • Frederick Naftolin The ovarian renin-angiotensin system

                          Affari 2 Key Lecture 15:45 → 16:15
                          Current perspectives on the management of Uterine Fibroids

                          Chairperson/s: Andrea R. Genazzani

                          • Jacques Donnez Current perspectives on the management of Uterine Fibroids

                          Verde Key Lecture 15:45 → 16:15
                          Stress, emotional eating, and reproductive function

                          Chairperson/s: Bruno Lunenfeld

                          • Sarah Berga Stress, emotional eating, and reproductive function

                          16:30 Friday 9th

                          Auditorium Symposium 16:30 → 18:00
                          Breast cancer: clinical impact of latest investigations

                          Chairperson/s: Alfred Mueck , Stefanos Zervoudis

                          • Nicoletta Biglia Breast cancer screening today
                          • Anne Gompel When can HT be used in those at increased risk of breast cancer ?
                          • Xiangyan Ruan Membrane-bound-Progesterone-Receptor can predict prognosis of breast cancer
                          • Christian Singer Endocrine therapy and fertility in young breast cancer patients

                          Affari 1 Symposium 16:30 → 18:00
                          Depression and cognition in midlife women

                          Chairperson/s: Michèle Lachowsky , Pauline Maki

                          • Luis Garcia-Segura Estrogenic regulation of neuro-inflammation: implications for depression and cognition
                          • Alessandra Graziottin Osteoarthritis: a neglected trigger of neuroinflammation and depression in women
                          • Tory Eisenlohr-Moul Novel methods for clarifying the psychiatric effects of ovarian steroids across the female lifespan
                          • John Studd Estrogens and testosterone for reproductive depression

                          Affari 0 Symposium 16:30 → 18:00
                          Cardiovascular protection: the sex steroids challenges

                          Chairperson/s: Irene Lambrinoudaki , Peter Collins

                          • Frederick Naftolin Sex steroids block the initiation of atherosclerosis
                          • John Stevenson HRT for primary prevention of CHD
                          • Nestor Siseles Cardiovascular risk in climacteric women: when to begin the hormone treatment ?
                          • Tomi Mikkola Cardiovascular mortality risk and HRT

                          Affari 2 Symposium 16:30 → 18:00
                          Early pregnancy: a critical period with multiple affecting factors

                          Chairperson/s: Tomoyuki Fujii , Mary Stephenson

                          • Takeshi Maruo Thyroid hormone in trophoblast invasion and early pregnancy maintenance
                          • Howard Carp Management of antiphospholipid syndrome in pregnancy
                          • Robert Taylor Gap junctions and hormonal regulation of endometrial decidualization
                          • Mark Brincat The IVF/ICSI, early pregnancy interphase

                          Verde Symposium 16:30 → 18:00
                          Contraception: personalized regimens, new molecules

                          Chairperson/s: Nilson R. De Melo , Angelica Hirschberg

                          • Anna Glasier The advantages and disadvantages of long-acting reversible contraception (LARC)
                          • Johannes Bitzer Do will still need anti-androgenic progestogens?
                          • Adolf Eduard Schindler The role of progestogen-only-pills (POP’s) for contraception and non-contraceptive indications
                          • JEAN MICHEL FOIDART Introducing the first NEST in contraception (native estrogen with selective tissue activity)

                          Affari 4 Oral Presentation 16:30 → 18:00
                          Vulvo-Vaginal Atrophy , Bone effects and other Menopause symptoms

                          Chairperson/s: Santiago Palacios , Tobias De Villiers

                          • Emilia Berin Resistance training for hot flushes in postmenopausal women
                          • Simin Taavoni Effect of Valerain Capsules on Menopausal Symptoms: A Triple Blind Randomized Clinical Trial
                          • Sebastian Mirkin Symptomatic vulvar and vaginal atrophy (VVA) relief was achieved with TX-004HR, an investigational vaginal estradiol softgel capsule, with negligible to very low systemic absorption of estradiol: PK comparison with systemic and a vaginal estradiol
                          • Zorana Arizanovic Vasomotor symptoms and blood pressure in menopausal women
                          • Muhammad Fidel Ganis Siregar Relationships of Cognitive Function Based on Informant Questionaire Cognitive Decline (IQCODE) in the elderly with serum estradiol levels on paramedic with menopause age in Indonesia
                          • Thomas Stevenson Effect of HRT on inter-vertebral disc height: data from a prospective randomised trial
                          • Evaggelia Karopoulou Association between calcium metabolism and arterial stiffness in asymptomatic postmenopausal women.
                          • Marta Caretto Effects of six-month oral dehydroepiandrosterone supplementation on beta-endorphin response to oral glucose tolerance test in obese and non-obese pre and postmenopausal women
                          • Ana Osorio Ruiz The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review
                          • Lubov V. Kuznetsova factors affecting the effectiveness of therapy of osteopenic syndrome in postmenopausal women
                          • Svetlana Yureneva Vaginal symptoms and microbiotа in postmenopausal women
                          • Irene Zolfaroli Plasmatic Lipids and bone, the link for new treatments

                          Onice Oral Presentation 16:30 → 18:00
                          Pregnancy: gestational diabetes mellitus

                          Chairperson/s: Gary Ventolini , Paolo Mannella

                          • Ofelia Bettikher The vascular reactivity to serotonin of human chorionic plate arteries in gestational diabetes, preeclampsia and both pregnancy complications
                          • Fareha Fauzan Meta-analysis: Genetic Polymorphisms associated with Gestational Diabetes Mellitus
                          • Diana-Elena Comandasu Pregnancy related diabesity and poor fetal outcome: the key role of inflammation
                          • changling DUAN Pregnancy Complications of Polycystic Ovary Syndrome
                          • Salvatore Giovanni Vitale Myo-inositol supplementation to prevent gestational diabetes and effects on body composition in overweight non-obese women: a randomized placebo-controlled trial
                          • Polina Abramicheva Hyperprolactinemia in cholestasis of pregnancy is associated with decreased renal outer medulla Na+/K+-АТPase activity and elevation of pSTAT5
                          • Deng Ao Early risk-prediction models of Gestational diabetes mellitus in Chinese women using support vector machine model
                          • Swati Sharma Evaluation of association of vitamin D insufficiency with gestational diabetes mellitus
                          • Alexandra Onopriychuk Markers of endothelial dysfunction and coagulation in gestational diabetes mellitus
                          • Alexandra Onopriychuk Placental expression of the angiogenic growth factors in gestational diabetes mellitus
                          • Joanna Marie Paulino-Morente Cerebral Cavernous Malformation Activated By Elevated Vascular Endothelial Growth Factor in Placenta, Gestational Diabetes Mellitus, and Hepatic Hemangioma in a Young Pregnant: A Case Report

                          Sala 4 Oral Presentation 16:30 → 18:00
                          Endometriosis, DUB and Uterine Fibroids: symptoms and treatments

                          Chairperson/s: Stefano Angioni , Nicola Pluchino

                          • Silvia Baggio Influence of ulipristal acetate therapy on uterine fibroid-related symptoms and on uterine and fibroid volume and vascularity indices assessed by ultrasound
                          • Hugo Maia The Effect of the Association of Miodesin with Gestrinone on Deep Endometriosis Pain
                          • Aleksandar Jurisic What can be expected from Ulipristal in the treatment of uterine fibroids?
                          • Alexandra Mihaila Clinical and paraclinical considerations interesting the hormonal therapy in women with endometriosis
                          • Roxana Matasariu Progesterone treatment in endometriosis- immunohystochemical variations
                          • Roxana Matasariu impact of endometriosis on physical, mental and social wellbeing – a qualitative study
                          • Ticiana Mira What else can we do? A complementary treatment for pain in deep endometriosis using electrotherapy
                          • Arsenii Molotkov Aromatase inhibitors in treatment of endometriosis in experiment and clinical trial
                          • Shara Borgato Uterine fibroids size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.
                          • Giovanni Grandi Dienogest influence on miRNA expression in tumor necrosis factor-α stimulated endometrial stromal cells from women with endometriosis

                          18:00 Friday 9th

                          Auditorium Symposium 18:00 → 19:30
                          Precision medicine and hormone therapy: right woman, right time, right regimen.

                          Chairperson/s: Tomi Mikkola , John Stevenson

                          • Roberta Brinton Diaz The perimenopause is personal: precision hormone therapy to make it precise
                          • Pauline Maki A scientific update on the critical window of hormone therapy and cognition: who, what, when?
                          • Regine Sitruk-Ware How to tailor progestin use to individual needs in the post-menopause
                          • Andrea R. Genazzani How long to treat and how adapt the hormone therapy to the overcoming needs

                          Affari 1 Symposium 18:00 → 19:30
                          Gynecological symptoms and psychosomatic health

                          Chairperson/s: Tory Eisenlohr-Moul , John Studd

                          • Liliana Gazzuola Rocca Adverse childhood or adult experiences and gynecological symptoms
                          • Tamaki Matsumoto-Takayanagi Autonomic nervous system activity and psychophysiological symptoms during the menstrual cycle
                          • Michèle Lachowksy Endometriosis and infertility, a psychosomatic approach

                          Affari 0 Symposium 18:00 → 19:30
                          PCO: ART and pregnancy outcomes

                          Chairperson/s: Pedro Barri , Luca Gianaroli

                          • Basil Tarlatzis PCOS: what is the preferred stimulation protocol for IVF ?
                          • Xiangyan Ruan Aromatase inhibitors plus HMG for infertile PCOS women
                          • Duru Shah AMH in PCOS and ART outcome
                          • Bart CJM Fauser Metabolic dysfunction in PCOS: implications for pregnancy and children outcomes

                          Affari 2 Symposium 18:00 → 19:30
                          Sexuality all the life

                          Chairperson/s: René Druckmann , Alessandra Graziottin

                          • Johannes Bitzer New sexualities – the internet and sex
                          • Angelica Hirschberg Hormonal contraception and impact on sexuality
                          • Rossella E. Nappi Genitourinary syndrome of menopause and impact on women’s life
                          • Susan Davis Sexual wellbeing and older women- what is the data?

                          Verde Symposium 18:00 → 19:30
                          Progesterone: the life time partner steroid

                          Chairperson/s: Howard Carp , Robert Taylor

                          • Luigi Devoto Different pathways of P-receptor complex in the process of ovulation
                          • Adolf Schindler Prevention or treatment of pregnancy disorders with progestogens
                          • Philippe Bouchard Progesterone: friend and /or foe on breast and CNS
                          • Alfred Mueck Vascular effects of progestogens

                          Affari 4 Oral Presentation 18:00 → 19:30
                          Androgen Insensitivity Syndrome and Adolescent Polycystic Ovary Syndrome

                          Chairperson/s: Salvatore Caruso , Zana Bumbuliene

                          • Takhmina Rasuleva LEPR p.Q223R polymorphism influences plasma leptin levels and body mass index in Uzbek obese women of childbearing age.
                          • VERA ANDREEVA The role of Leptin and and soluble Leptin Receptor Levels in pathogenesis of ovarian dysfunction in adolescent girls with obesity
                          • VERA ANDREEVA The role of Toll-like receptors in pathogenesis of insulin resistance and ovarian dysfunction in girls with obesity
                          • Elena Khashchenko Mitochondrial Dysfunction and Oxidative stress activation in Adolescent Girls with Polycystic Ovary Syndrome and Excessive Body Weight
                          • Sujata Kar Metformin versus OCP in adolescent PCOS girls: an RCT from India.
                          • Giulia Gava Bone mineral density in women with complete androgen insensivity syndrome
                          • Mukhlisa Shariksieva The occasion of 21CYP mutation in girls with premature adrenarche
                          • Despoina Apostolaki No Differences in Serum Brain-Derived Neurotrophic Factor between Overweight/Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome
                          • Giovana Maffazioli Evaluation of Reproductive Function in a Rat Model of Genetic Epilepsy Absence Seizures
                          • Vasileios Karountzos The role of Bulimia Nervosa in hormonal and metabolic profile, as well as in menstrual pattern, of overweight and obese adolescents
                          • Mary Grace Villafuerte Mixed Germ Cell Tumor in Androgen Insensitivity Syndrome: A Case Report

                          Onice Oral Presentation 18:00 → 19:30

                          Chairperson/s: David Serfaty , Gabriele Merki

                          • Melinda Vanya Differences in the use of contraception between Roma and non-Roma women in Hungary
                          • Pedro Antonio Regidor Clinical development of Ornibel® a new generation etonogestrel/Ethinylestradiol vaginal ring: Comparative bioavailability and tolerability vs Nuvaring ®
                          • Vitaly Tskhay Results of the operative surgery with severe forms of adenomyosis
                          • Mohd Faizal Ahmad Combined oral contraceptive pills ( COCPs ) versus nsaids in management of bleeding irregularities among implanon users
                          • Pedro Antonio Regidor Clinical development of Ornibel ® a new generation etonogestrel/ethinylestradiol vaginal ring: Comparative tolerability, acceptance and flexibility of the new ring with Nuvaring®
                          • Joanna Kacperczyk-Bartnik Global trends in use of birth control methods
                          • Albe Swanepoel Effect of two ethinyl estradiol and drosperinone containing combined oral contraceptives on whole blood clot viscoelasticity
                          • GIULIA GAVA The impact of counselling and no-cost provision of LARCs in women with repeat abortions in Italy.
                          • Muhammad Azrai Abu Vaginal bleeding irregularities and its perception among implanon users
                          • Aditi Chauhan Sperm impairing factor from Staphylococcus aureus as male contraceptive: An in vivo study

                          Sala 4 Oral Presentation 18:00 → 19:30
                          Assisted Reproduction Technologies: from maternal and paternal age impact to ovarian tissue transplantation

                          Chairperson/s: Cesare Aragona , Guido Ambrosini

                          • Maria Costanza Chiti A novel fibrin-based matrix for the creation of an artificial ovary prototype for human application
                          • Patrizia Monteleone Thyroid peroxidase identified in human granulosa cells
                          • Beatriz Alvaro Mercadal Working out the best AMH threshold for a good ovarian response in oocyte donors
                          • Georgios Scheiner-Bobis Physiological and pathophysiological relevance of ZIP9, a zinc transporter, androgen receptor, and G-protein-coupled signal transducer
                          • Sava Micic DNA fragmentation index (DFI) and seminal carnitine, with moderate accuracy, impact progressive sperm motility in oligoasthenozoospermc men treated with metabolic and essential nutrients
                          • Karina Cázarez Pérez Association between advanced paternal age, seminal quality and the dna fragmentation index
                          • Ludmila Barbakadze The value of AMH, AFC and age for prediction of IVF outcome
                          • Diego Daniel Manavella Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue
                          • Luciana Cacciottola In vivo characterization of metabolic activity and oxidative stress in grafted human ovarian tissue using microdialysis
                          • MacKenzie Purdy Does the co-flare in-vitro fertilization (ivf) protocol change the number of oocytes retrieved for women with diminished ovarian reserve (DOR)?

                          Saturday 10th March 2018

                          08:30 Saturday 10th

                          Affari 1 Meet the Experts 08:30 → 09:30
                          Population Council – ISGE Session: Novel options for women health protection

                          Chairperson/s: Rossella E. Nappi

                          • Regine Sitruk-Ware Vaginal rings for dual protection
                          • Anna Glasier Interventions to reduce unintended pregnancy rates

                          Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 → 11:30
                          Endometriosi e dolore pelvico cronico

                          Chairperson/s: Luigi Venturini

                          • Stefano Luisi Le basi fisiopatologiche dell’endometriosi e le scelte terapeutiche
                          • Stefano Angioni Chirurgia dell’endometriosi: quando e quanto radicale?
                          • Antonio La Marca La paziente con endometriosi alla ricerca di una gravidanza: come procedere ?
                          • Alessandra Graziottin Dolore pelvico cronico non da endometriosi : diagnosi e strategie terapeutiche

                          Affari 2 Meet the Experts 08:30 → 09:30
                          Obesity and reproduction: impact in pregnancy and at menopause

                          Chairperson/s: Fabio Facchinetti

                          • Eran Hadar Facing the Non Communicable Disease (NCD) global epidemic – it all starts in utero
                          • Peter Chedraui The metabolic syndrome a pro-inflammatory state before or after the menopause?

                          Verde Scientific Society Symposium 08:30 → 09:30
                          Women in her psychoneuroimmunoendocrinologycal universe – Organized by the Sociedad Argentina de Endocrinologia Ginecologica y Reproductiva (SAEGRE)

                          Chairperson/s: Manuel Noelting

                          • Sandra Demayo PCOS, Insulin- resistant and mood disorder: an intricately overlapped story
                          • Amalia Monastero Stress and the onset of oncological pathologies: the worst oulet
                          • Susana Pilnik Transition to menopause: emotional vulnerability to falling hormones

                          Affari 4 Scientific Society Symposium 08:30 → 09:30
                          New research in Chinese women – Organized by the Chinese Society of Gynecological Endocrinology

                          Chairperson/s: Xiangyan Ruan , Alfred Mueck

                          • Xiangyan Ruan Ovarian tissue retransplantation in cancer patients first center in China
                          • wei huang PCOS with metabolic disorders: Treatment wird insulin sensitizer and lifestyle change
                          • Jinfang Lin Management of PCOS patients with endometrial hyperplasia and early adenocarcinoma

                          Onice Scientific Society Symposium 08:30 → 09:30
                          Unmet needs in sexual care – Organized by the Federazione Italiana di Sessuologia Scientifica (FISS)

                          Chairperson/s: Vieri Boncinelli , Salvatore Caruso

                          • Chiara Simonelli Female genital-pelvic pain disorders
                          • Elena Lenzi Female sexual dysfunctions and couple-based clinical interventions
                          • Salvatore Caruso No drug treatment for women with sexual dysfunction

                          Sala 4 Scientific Society Symposium 08:30 → 09:30
                          Metabolic impact of the climacteric women (Organized by the Chilean Society of Gynecological Endocrinology (SOCHEG)

                          Chairperson/s: Patricio Barriga , Luigi Devoto

                          • Sergio Brantes Clinical responses to the metabolic risk associated with the peri and post menopause
                          • Pablo Lavin Metabolic Syndrome in Chilean women and their oncological risk in breast and endometrium
                          • Marcela Lopez Hormonal and non-hormonal therapeutic strategies to reduce cardiovascular risk in women with high metabolic risk

                          09:45 Saturday 10th

                          Affari 1 Symposium 09:45 → 11:15
                          Menopause: suggestions from nature

                          Chairperson/s: Cuauhtemoc Celis , Ludwig Kiesel

                          • David Archer Novel treatment of vulvovaginal atrophy with prasterone:an approach based upon physiology
                          • James Pickar Novel oral, continuous-combined solubilized 17β-estradiol and natural progesterone provides endometrial protection: Comparison of two randomized controlled trials
                          • Ewald Boschitsch Menopause Hormone Therapy: the natural way is the safest!
                          • Lydia Marie-Scemama Recent international recommandations about HRT: what impact on gynecologists and patients in 2018?

                          Affari 2 Symposium 09:45 → 11:15
                          ART – Time is moving: new difficulties and new possibilities

                          Chairperson/s: Bart Fauser , Joseph Schenker

                          • Luca Gianaroli 40 years after Louise Brown
                          • Paolo Artini Collapse of blastocysts is correlated to implantation success or not ?
                          • Pedro N. Barri Uterine factor in IVF repeated implantation failure

                          Verde Scientific Society Symposium 09:45 → 11:15
                          Hormonal contraception – needs, possibilities and safety: the debate is still going on – Organized by the European Society of Gynecology (ESG)

                          Chairperson/s: Andrzej Milewicz , Mark Brincat

                          • David Serfaty How to reduce unintended pregnancies and abortions
                          • Johannes Bitzer Fertility control among populations living in poverty- an ethical taboo or an urgent necessity?
                          • Ulisse Gaspard Numerous Progestins could be listed as Fourth Generation progestins
                          • Sven Skouby Hormonal contraception: the ghost of pill scare still rides!

                          Affari 4 Scientific Society Symposium 09:45 → 11:15
                          Endocrine disorders during pregnancy – Organized by the Hungarian Society of Gynecological Endocrinology

                          Chairperson/s: George Bartfai , Andras Szilagyi

                          • Attila Jakab Adverse perinatal outcome of pregnancies after ART: twins are responsible for everything?
                          • Szabolcs Várbíró Effect of PCOS and vitamin D deficiency and supplementation on fertility and pregnancy outcomes;
                          • Tamás Deli Effect of endocrine disorders on fertility and fetal and maternal obstetrical outcomes
                          • Imre Kun Tormasi Association of pathological tyrosine isoforms with parameters of hematopoiesis in
                            hyperfiltrating physiological pregnant women
                          • Monika Orosz Hyperprolactinaemia in young women: treatment and follow-up of the infertile patient
                          • Petra Merkely Gender differences in cardiovascular exercise adaptation in a rat model
                          • Szilvia Csehely Laboratory and etiology characteristics of PCOS phenotypes

                          Onice Oral Presentation 09:45 → 11:15
                          Polycystic Ovary Syndrome: obesity and metabolic syndrome impact on therapies

                          Chairperson/s: Blazej Meczekalski , Archil Khomasuridze

                          • Moamar Al-Jefout Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
                          • Maria Khmil Benefits of the use of Myo-inositol (FT 500Plus) in women with polycystic ovary syndrome undergoing in-vitro fertilization in antagonist protocols with agonist trigger to prevent the OHSS.
                          • Meeta Meeta Performance of surrogate markers for insulin resistance in women with PCOS
                          • Gokce Anik Ilhan Galectin-3 as a novel biomarker in women with PCOS.
                          • Emma Öberg Improved menstrual function in obese women with polycystic ovary syndrome after behavioral modification intervention – a randomized controlled trial
                          • Valentina Galiano Polycystic ovary syndrome (PCOS): Predictors of response to Metformin treatment
                          • Valeria Versace The resting metabolic rate is not altered in women with polycystic ovary syndrome: a sensewear armband study.
                          • Giovana Maffazioli Evaluation of the Impact of Low L-Carnitine Levels in Metabolic and Hormonal Profile of Polycystic Ovary Syndrome
                          • Giulia Bonelli Classic phenotype of PCOS: does the ultrasound morphology of the ovary associate with the metabolic risk?
                          • Georgina Carranza Escalera Frequency of Fatty Liver Disease in Polycystic Ovary Syndrome patients by phenotype A, B, C and D in the clinic of Endocrine Gynecology of the “Hospital Juárez de México”
                          • Alina Naydukova Prediction of therapeutic effect of metformin in patients with polycystic ovary syndrome
                          • Rodrigo Marcondes Impact of metformin and exercise, isolated or associated, on morphology and oxidative stress in adipose tissue of a polycystic ovary syndrome rat model
                          • Vinicius Cestari do Amaral Effects of estrogen on GLUT4 and IRS1 expression in SGBS-adipocytes

                          Sala 4 Oral Presentation 09:45 → 11:15
                          Quality of Life and Sexuality

                          Chairperson/s: Tamaki Matsumoto , Julia Savochkina

                          • Raquel Picó Symptoms and quality of life in women of advanced age as assessed with the mrs scale.
                          • Melinda Bartfai Measuring of quality of life and health characteristics among 40-79 old population in Hungary
                          • Sheryl Kingsberg Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
                          • Linda Vignozzi Psychological and sexual correlates of sexual abuse in women with sexual dysfunction
                          • Linda Vignozzi Psychobiological correlates of vaginismus: an exploratory analysis
                          • mancini ilaria Safety of 5-years testosterone treatment in Female to Male subjects
                          • JOULEN MO-CARRASCAL Abdominal hysterectomy as a risk factor to psychological stress, alteration of sleep and quality of life
                          • Lavinia Domenici Improving Vaginal Health And Sexual Functioning In Gynecologic Cancer Survivors With Probiotics: A Pilot Study
                          • Maria Fernanda Mercado-Lara Comparison of quality of life in climatrics of two colombian ethnics: evaluation with scale cervantes
                          • Angelica Monterrosa-Blanco Insomnia and sexual dysfunction associated with severe deterioration of quality of life in sexually active hysterectomys
                          • Leidy Duran-Mendez Factors associated with sexuality disorders in menopausal colombians
                          • Anastasia Armeni Dopamine receptor D4 (DRD4) gene and brain-derived growth factor (BDNF) gene polymorphisms enhance the impact of estrogen receptor α (ERα) gene polymorphism on female sexuality.

                          11:15 Saturday 10th


                          11:45 Saturday 10th

                          Affari 1 Key Lecture 11:45 → 12:15
                          Molecular pathways of ageing

                          Chairperson/s: Andrzej Milewicz

                          • Bruno Lunenfeld Molecular pathways of ageing

                          Affari 0 Key Lecture 11:45 → 12:15
                          Pituitary adenomas- clinical challenges

                          Chairperson/s: George Creatsas

                          • Joseph Schenker Pituitary adenomas- clinical challenges

                          Affari 2 Key Lecture 11:45 → 12:15
                          Significance of estrogens metabolites in the pathophysiology of PCOS

                          Chairperson/s: Sarah Berga

                          • Luigi Devoto Significance of estrogens metabolites in the pathophysiology of PCOS

                          Verde Key Lecture 11:45 → 12:15
                          Menopause hormone therapy after 65: available data, risks and benefits

                          Chairperson/s: Frederick Naftolin

                          • Martin Birkhaeuser Menopause hormone therapy after 65: available data, risks and benefits

                          12:30 Saturday 10th

                          Affari 1 Symposium 12:30 → 14:00
                          Post Reproductive Health

                          Chairperson/s: David Archer , Nestor Siseles

                          • Margaret Rees Managing menopause and post reproductive health: beyond hormones and medicines
                          • Cuauhtemoc Celis-Gonzalez Straw and the most frequent co-morbidities
                          • Sandro Scattareggia, Claudia Buzzi, Andrea Giannini The development of an adaptive application to empower women into a healthy life at menopause – the Vita Nova project
                          • Damir Franic Regenerative medicine in post-menopause

                          Affari 0 Symposium 12:30 → 14:00
                          Puberty and adolescence

                          Chairperson/s: Efthymios Deligeoroglou , Charles Sultan

                          • Blazej Meczekalski Kisspeptin role in functional hypothalamic amenorrhea
                          • Camil Castelo Branco Management of transsexuality in an outpatient gynecologic area
                          • George Creatsas Dysfunctional uterine bleeding in adolescence
                          • Vincenzina Bruni Premature ovarian insufficiency therapy in young women

                          Affari 2 Symposium 12:30 → 14:00
                          Vitamin D

                          Chairperson/s: Ulysse Gaspard , Ewald Boschitsch

                          • Faustino Perez Lopez Maternal vitamin D and reproductive outcomes
                          • Andrzej Milewicz Serum vitamine D levels and VDR polymorphisms in women with PCOS
                          • Mark Brincat Vitamin D in PCO and endometriosis. Levels and significance
                          • Yuliya Savochkina Vitamin D level in women with anovulatory disfunction

                          Verde Symposium 12:30 → 14:00
                          Contraception: difficult cases

                          Chairperson/s: Johannes Bitzer , Kristina Gemzell-Danielsson

                          • Rossella E. Nappi Hormonally-related headaches
                          • Nilson R. De Melo Contraception in menopausal transition
                          • Kristina Gemzell Danielsson Contraception for teenagers and young women
                          • Peter Chedraui Contraception in women with cardiovascular risk factors

                          Affari 4 Oral Presentation 12:30 → 14:00
                          Assisted Reproduction Technologies: from ovulation induction to luteal phase support

                          Chairperson/s: Patrizia Monteleone , Antonio La Marca

                          • Jean Rouleau Progesterone levels higher than 1,7 ng/ml on the day of hCG are associated with lower clinical pregnancy rates in hcg-triggered gnrh antagonist cycles
                          • Cristina Cossetti Effect of specific nutrients on ovulation, oocytes development, gene expression and coupling success in mice
                          • Fatemehsadat Hoseini A randomized controlled trial of gonadotropinreleasing hormone agonist versus gonadotropinreleasing hormone antagonist in Iranian infertile couples: oocyte gene expression
                          • Shabnam Fayezi Effect of oleic acid on in vitro maturation of oocytes collected from polycystic ovaries and subsequent preimplantation embryonic development
                          • Romualdo Sciorio Blastocysts collapse as an embryo marker of low implantation potential a Time-Lapse study
                          • Hui Long Age related nomogram of serum Anti-Mullerian hormone (AMH) and its prediction of ovarian response in female cynomolgus monkeys undergoing assisted reproductive technology treatment
                          • Sharon Vanetik Day two post retrieval 1,500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger – a proof of concept study.
                          • Hui Lim Does using the combined oral contraceptive pill for scheduling in the GnRH antagonist protocol for IVF/ICSI reduce the pregnancy rate?
                          • Julia Bosdou Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in-vitro fertilization (IVF): a systematic review and meta-analysis
                          • Emina Ejubovic The relationship between the preovulatory and postovulatory progesterone serum concentration and the outcome of the in vitro fertilization
                          • Mohamed Basly Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a Prospective randomised controlled trial (RCT)

                          Onice Oral Presentation 12:30 → 14:00
                          Pregnancy and Labour

                          Chairperson/s: Stefano Luisi , Eran Hadar

                          • Michaela dušková Maternal smoking and changes in the fetal steroidogenesis – is there difference due to sex of child?
                          • Diptika Tiwari Detrimental effect of progesterone pathway deregulation modulated immune activation in preterm delivery and outcome in hepatitis e virus (hev) infected pregnancy cases from northeast india
                          • Franzel Alvarez Hott Precocious pregnant teenagers treated in hospital santiago oriente dr. luis tisné brousse: epidemiological profile and perinatal outcomes.
                          • Andrea Sepulveda Perinatal results in premature rupture of fetal membranes in pregnancies under 25 weeks, local experience
                          • Andreas Zouridis Intauterine HPV transmission – a systematic review of the literature and meta-analysis
                          • Muhammad Azrai Abu Is neonatal outcome of the second twin promising?
                          • Chunfeng Yun Prevalence and social factors for birth trauma caused disability among Chinese children: A national survey
                          • Maximilian Brincat A comprehensive literature review on the diagnosis and management of interstitial ectopic pregnancies.
                          • Antonio Simone Laganà Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-Lactalbumin in pregnant women affected by Iron Deficiency Anemia: preliminary results from a prospective, double-blind, randomized controlled trial

                          Sala 4 Oral Presentation 12:30 → 14:00
                          Premature Ovarian Insufficiency

                          Chairperson/s: Lydia Scemama , James Pickar

                          • Iulia Potorac Fluctuating primary ovarian insufficiency in a case of type 2 autoimmune polyendocrinopathy
                          • Asma Sassi Premature ovarian Insufficiency: a case report of a particular syndromic association
                          • Svetlana Dragojevic Dikic POI – current hormonal approach in optimizing fertility-the role of melatonin
                          • Anna Szeliga Bone mineral density in patients with premature ovarian insufficiency. The role of hormonal replacement therapy.
                          • Marta Hentschke Is ovulation induction in patients with polycystic ovary syndrome associated with negative maternal outcomes?
                          • Camila Menezes Lima Psychological evaluation in women with premature ovarian insufficiency using Hormonal therapy: depression, anxiety, and stress
                          • Andrea Giraldo Body fat distribution in women with premature ovarian insufficiency on estroprogestative hormone therapy
                          • Helena Giraldo Interferential current: a new treatment for lubrication and dyspareunia complaints in women with premature ovarian failure using hormone therapy

                          14:00 Saturday 10th

                          Affari 1 Closing Ceremony 14:00 → 14:15